Literature DB >> 10991945

Age-related changes in aggrecan glycosylation affect cleavage by aggrecanase.

M A Pratta1, M D Tortorella, E C Arner.   

Abstract

Aggrecan degradation involves proteolytic cleavage of the core protein within the interglobular domain. Because aggrecan is highly glycosylated with chondroitin sulfate (CS) and keratan sulfate (KS), we investigated whether glycosylation affects digestion by aggrecanase at the Glu(373)-Ala(374) bond. Treatment of bovine aggrecan monomers to remove CS and KS resulted in loss of cleavage at this site, suggesting that glycosaminoglycans (GAGs) play a role in cleavage at the Glu(373)-Ala(374) bond. In contrast, MMP-3 cleavage at the Ser(341)-Phe(342) bond was not affected by glycosidase treatment of aggrecan. Removal of KS, but not CS, prevented cleavage at the Glu(373)-Ala(374) bond. Thus, KS residues may be important for recognition of this cleavage site by aggrecanase. KS glycosylation has been observed at sites adjacent to the Glu(373)-Ala(374) bond in steer aggrecan, but not in calf aggrecan (Barry, F. P., Rosenberg, L. C., Gaw, J. U., Gaw, J. U., Koob, T. J., and Neame, P. J. (1995) J. Biol. Chem. 270, 20516-20524). Interestingly, although we found that aggrecanase degraded both calf and steer cartilage aggrecan, the proportion of fragments generated by cleavage at the Glu(373)-Ala(374) bond was higher in steer than in calf, consistent with our observations using aggrecan treated to remove KS. We conclude that the GAG content of aggrecan influences the specificity of aggrecanase for cleavage at the Glu(373)-Ala(374) bond and suggest that age may be a factor in aggrecanase degradation of cartilage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991945     DOI: 10.1074/jbc.M006201200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Variations in aggrecan structure modulate its susceptibility to aggrecanases.

Authors:  Peter J Roughley; James Barnett; Fengrong Zuo; John S Mort
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

2.  Pharmacophore development and screening for discovery of potential inhibitors of ADAMTS-4 for osteoarthritis therapy.

Authors:  Priyanka Verma; Krishna Dalal; Madhu Chopra
Journal:  J Mol Model       Date:  2016-07-11       Impact factor: 1.810

3.  Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.

Authors:  Jae-Hyuk Yi; Yasuhiro Katagiri; Bala Susarla; David Figge; Aviva J Symes; Herbert M Geller
Journal:  J Comp Neurol       Date:  2012-10-15       Impact factor: 3.215

4.  An enzyme-sensitive PEG hydrogel based on aggrecan catabolism for cartilage tissue engineering.

Authors:  Stacey C Skaalure; Stanley Chu; Stephanie J Bryant
Journal:  Adv Healthc Mater       Date:  2014-10-08       Impact factor: 9.933

5.  Chondroitin sulfate N-acetylgalactosaminyltransferase 1 is necessary for normal endochondral ossification and aggrecan metabolism.

Authors:  Takashi Sato; Takashi Kudo; Yuzuru Ikehara; Hiroyasu Ogawa; Tomoko Hirano; Katsue Kiyohara; Kozue Hagiwara; Akira Togayachi; Masatsugu Ema; Satoru Takahashi; Koji Kimata; Hideto Watanabe; Hisashi Narimatsu
Journal:  J Biol Chem       Date:  2010-12-10       Impact factor: 5.157

6.  Hyaluronate degradation as an alternative mechanism for proteoglycan release from cartilage during interleukin-1beta-stimulated catabolism.

Authors:  Robert Sztrolovics; Anneliese D Recklies; Peter J Roughley; John S Mort
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

7.  The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.

Authors:  Robert Sztrolovics; Robert J White; Peter J Roughley; John S Mort
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

8.  Molecular Engineering of Pericellular Microniche via Biomimetic Proteoglycans Modulates Cell Mechanobiology.

Authors:  Elizabeth R Kahle; Biao Han; Prashant Chandrasekaran; Evan R Phillips; Mary K Mulcahey; X Lucas Lu; Michele S Marcolongo; Lin Han
Journal:  ACS Nano       Date:  2022-01-11       Impact factor: 18.027

9.  Potential plasma biomarkers for progression of knee osteoarthritis using glycoproteomic analysis coupled with a 2D-LC-MALDI system.

Authors:  Isao Fukuda; Takeshi Ishihara; Shigeki Ohmachi; Ikue Sakikawa; Atsushi Morita; Minoru Ikeda; Shoji Yamane; Tomoko Toyosaki-Maeda; Yoshihiko Takinami; Hiroyuki Okamoto; Yoshito Numata; Naoshi Fukui
Journal:  Proteome Sci       Date:  2012-06-06       Impact factor: 2.480

10.  Roles of metalloproteinase-3 and aggrecanase 1 and 2 in aggrecan cleavage during human meniscus degeneration.

Authors:  Gintaro Ishihara; Toshihisa Kojima; Yoshimichi Saito; Naoki Ishiguro
Journal:  Orthop Rev (Pavia)       Date:  2009-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.